Loading...
First Round of Abstract Submission Ends: Dec 31, 2026
Extended Early Bird Ends: Oct 28, 2026

Keynote Speakers

Dr. Ru-song Zhao
Shandong University, China
Title: Applications of Endometrial Organoids in Reproductive Biology and Drug Screening
Rusong Zhao, PhD, is an associate professor and master's supervisor in the State Key Laboratory of Reproductive Medicine and Offspring Health at Nanjing Medical University. Her translational research bridges fundamental mechanistic discovery with unmet clinical needs in human reproductive health, focusing on post-implantation human embryogenesis, maternal–fetal crosstalk, endometrial receptivity and the modeling of human diseases. She received her PhD in obstetrics and gynecology from Shandong University in 2022.

Drawing on well-annotated clinical specimen cohorts, Dr. Zhao's laboratory integrates stem-cell engineering, spatial imaging and spatiotemporal multi-omics profiling to dissect the molecular and cellular origins of adverse pregnancy outcomes from both the maternal and fetal perspectives, while developing regenerative strategies for the embryo implantation niche using human endometrial organoids, stem-cell platforms, natural bioactive agents and functional biomaterials. Her current areas of research include: 1) the construction, regeneration and translational validation of human endometrial organoids in disease modeling; 2) maternal–fetal interaction and the mechanisms of recurrent implantation failure; 3) embryonic organogenesis in pathological pregnancy and the mechanisms and interventional modulation of human oocyte in vitro maturation.

As first or corresponding author, Dr. Zhao has published 11 peer-reviewed articles in leading international journals, including Cell Stem Cell, Nature Cell Biology, eLife, Science China Life Sciences and Cell Proliferation, and holds five granted Chinese invention patents. Her research is supported by the National Natural Science Foundation of China, the National Key Research and Development Program of China, the National Postdoctoral Program of China and a Key Laboratory of the National Health Commission. She also serves as a Youth Committee Member of the Specialized Committee for Stem Cell Technology and Clinical Application Research, Shandong Medical Association.
Prof. Mizrahi Reuveni Miri
Reichman University, Israel
Title: Her Physiological Age: A New Lens on Women’s Health and Longevity
Will update soon.
Dr. Sri Kisha
Universiti Malaya Medical Centre, Malaysia
Title: The Next Era of Gynaecological Oncology: Precision Medicine, Immunotherapy and Antibody–Drug Conjugates
Dr. Sri Kisha Subramaniam is a Consultant Clinical Oncologist and Senior Lecturer at Universiti Malaya Medical Centre, recognised for her contributions to oncology, research, education, and healthcare leadership. Prior to specialising in oncology, she served as Deputy Head of Vector-Borne Disease Control at the Melaka State Health Department in Malaysia where she contributed to public health leadership and disease control at the state level.

Her clinical expertise spans head and neck, lung, breast, and gynaecological cancers, with a strong focus on multidisciplinary cancer care, precision oncology, radiotherapy, and systemic therapy. Her research is internationally recognised, and she is actively involved in multiple clinical trials and research collaborations. She also serves on numerous national and international committees, advisory boards, and guideline-development panels, contributing to the advancement of oncology practice and standards of care.

Dr. Kisha has received several prestigious recognitions, including the ASCO Leadership for Women in Oncology Award and the ASCO International Research Scholar Award. She has represented Malaysia at major international scientific meetings and has contributed as a speaker, faculty member, and researcher at forums including ASCO, MASCC/ISOO, and ASCOMOS, among others.

Beyond her clinical and research work, Dr. Kisha is deeply committed to oncology education, mentorship, and specialist training. As Programme Coordinator for the Master of Clinical Oncology at Universiti Malaya, she plays a key role in the training and development of future oncology specialists in Malaysia. She is also an active mentor to oncology trainees and early-career clinicians, supporting the development of the next generation of cancer specialists.